Aging-associated subpopulations of human CD8+ T-lymphocytes identified by their CD28 and CD57 phenotypes

Archives of Gerontology and Geriatrics

Volumn 61, Issue 3, 2015, Pages 494-502

  Onyema, Oscar Okwudiri ^a   Njemini, Rose ^a   Forti, Louis Nuvagah ^a   Bautmans, Ivan ^a   Aerts, Joeri L ^b   De Waele, Marc ^c   Mets, Tony ^a,c  

^a FACULTY OF MEDICINE AND PHARMACY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

CD28; CD57; Cellular aging; CXCR2; P16; P21

Indexed keywords

CD28 ANTIGEN; CD45RO ANTIGEN; CD57 ANTIGEN; CHEMOKINE RECEPTOR CCR5; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN BCL 2; PROTEIN P16; PROTEIN P21; BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL AGING; CELL DIFFERENTIATION; CELL HOMING; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; T LYMPHOCYTE SUBPOPULATION; AGED; AGING; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; PROCEDURES;

AGED; AGING; ANTIGENS, CD28; ANTIGENS, CD57; BIOMARKERS; CD8-POSITIVE T-LYMPHOCYTES; CELL AGING; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; PHENOTYPE;

EID: 84943449487     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2015.08.007     Document Type: Article

References (47)

1. Acosta J.C., O'Loghlen A., Banito A., Guijarro M.V., Augert A., Raguz S., et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008, 133:1006-1018.
2. Aggarwal S., Gupta S. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. The Journal of Immunology 1998, 160:1627-1637.
3. Borthwick N.J., Lowdell M., Salmon M., Akbar A.N. Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis. International Immunology 2000, 12:1005-1013.
4. Brenchley J.M., Karandikar N.J., Betts M.R., Ambrozak D.R., Hill B.J., Crotty L.E., et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003, 101:2711-2720.
5. Chen L., Park S.M., Tumanov A.V., Hau A., Sawada K., Feig C., et al. CD95 promotes tumour growth. Nature 2010, 465:492-496.
6. Chong L.K., Aicheler R.J., Llewellyn-Lacey S., Tomasec P., Brennan P., Wang E.C. Proliferation and interleukin 5 production by CD8hi CD57+ T cells. European Journal of Immunology 2008, 38:995-1000.
7. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006, 443:350-354.
8. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:9363-9367.
9. Dohoney K.M., Guillerm C., Whiteford C., Elbi C., Lambert P.F., Hager G.L., et al. Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage. Oncogene 2004, 23:49-57.
10. Effros R.B. Loss of CD28 expression on T lymphocytes: a marker of replicative senescence. Developmental and Comparative Immunology 1997, 21:471-478.
11. Effros R.B. Replicative senescence in the immune system: impact of the Hayflick limit on T-cell function in the elderly. American Journal of Human Genetics 1998, 62:1003-1007.
12. Erickson S., Sangfelt O., Heyman M., Castro J., Einhorn S., Grander D. Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence. Oncogene 1998, 17:595-602.
13. Fagnoni F.F., Vescovini R., Passeri G., Bologna G., Pedrazzoni M., Lavagetto G., et al. Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood 2000, 95:2860-2868.
14. Fukada K., Sobao Y., Tomiyama H., Oka S., Takiguchi M. Functional expression of the chemokine receptor CCR5 on virus epitope-specific memory and effector CD8+ T cells. The Journal of Immunology 2002, 168:2225-2232.
15. Geginat J., Sallusto F., Lanzavecchia A. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. Journal of Experimental Medicine 2001, 194:1711-1719.
16. Herbig U., Jobling W.A., Chen B.P., Chen D.J., Sedivy J.M. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Molecular Cell 2004, 14:501-513.
17. Hingorani R., Bi B., Dao T., Bae Y., Matsuzawa A., Crispe I.N. CD95/Fas signaling in T lymphocytes induces the cell cycle control protein p21cip-1/WAF-1, which promotes apoptosis. The Journal of Immunology 2000, 164:4032-4036.
18. Ibegbu C.C., Xu Y.X., Harris W., Maggio D., Miller J.D., Kourtis A.P. Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57. The Journal of Immunology 2005, 174:6088-6094.
19. Jackson J.G., Pereira-Smith O.M. p53 is preferentially recruited to the promoters of growth arrest genes p21 and GADD45 during replicative senescence of normal human fibroblasts. Cancer Research 2006, 66:8356-8360.
20. Jenkins L.M., Durell S.R., Mazur S.J., Appella E. p53 N-terminal phosphorylation: a defining layer of complex regulation. Carcinogenesis 2012, 33:1441-1449.
21. Krammer P.H. CD95's deadly mission in the immune system. Nature 2000, 407:789-795.
22. Kurz D.J., Decary S., Hong Y., Erusalimsky J.D. Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. Journal of Cell Science 2000, 113(Pt. 20):3613-3622.
23. Labalette M., Leteurtre E., Thumerelle C., Grutzmacher C., Tourvieille B., Dessaint J.P. Peripheral human CD8(+)CD28(+)T lymphocytes give rise to CD28() progeny, but IL-4 prevents loss of CD28 expression. International Immunology 1999, 11:1327-1336.
24. Liu Y., Sanoff H.K., Cho H., Burd C.E., Torrice C., Ibrahim J.G., et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell 2009, 8:439-448.
25. Mendez-Lagares G., Garcia-Perganeda A., del Mar del Pozo-Balado M., Genebat M., Ruiz-Mateos E., Garcia Garcia M., et al. Differential alterations of the CD4 and CD8 T cell subsets in HIV-infected patients on highly active antiretroviral therapy with low CD4 T cell restoration. The Journal of antimicrobial chemotherapy 2012, 67:1228-1237.
26. Mitchell K., Iadarola M.J. RT-PCR analysis of pain genes: use of gel-based RT-PCR for studying induced and tissue-enriched gene expression. Methods in Molecular Biology 2010, 617:279-295.
27. Njemini R., Demanet C., Mets T. Aging-related differences in basal heat shock protein 70 levels in lymphocytes are linked to altered frequencies of lymphocyte subsets. Aging Cell 2008, 7:498-505.
28. Noppe G., Dekker P., de Koning-Treurniet C., Blom J., van Heemst D., Dirks R.W., et al. Rapid flow cytometric method for measuring senescence associated beta-galactosidase activity in human fibroblasts. Cytometry A 2009, 75:910-916.
29. Olsson J., Wikby A., Johansson B., Lofgren S., Nilsson B.O., Ferguson F.G. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mechanisms of Ageing and Development 2000, 121:187-201.
30. Onyema O.O., Njemini R., Bautmans I., Renmans W., De Waele M., Mets T. Cellular aging and senescence characteristics of human T-lymphocytes. Biogerontology 2012, 13:169-181.
31. Pera A., Campos C., Corona A., Sanchez-Correa B., Tarazona R., Larbi A., et al. CMV latent infection improves CD8+ T response to SEB due to expansion of polyfunctional CD57+ cells in young individuals. PUBLIC LIBRARY OF SCIENCE 2014, 9:e88538.
32. Peter M.E., Budd R.C., Desbarats J., Hedrick S.M., Hueber A.O., Newell M.K., et al. The CD95 receptor: apoptosis revisited. Cell 2007, 129:447-450.
33. Petrovas C., Chaon B., Ambrozak D.R., Price D.A., Melenhorst J.J., Hill B.J., et al. Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. The Journal of Immunology 2009, 183:1120-1132.
34. Rincheval V., Renaud F., Lemaire C., Godefroy N., Trotot P., Boulo V., et al. Bcl-2 can promote p53-dependent senescence versus apoptosis without affecting the G1/S transition. Biochemical and Biophysical Research Communications 2002, 298:282-288.
35. Rodier F., Campisi J. Four faces of cellular senescence. Journal of Cell Biology 2011, 192:547-556.
36. Ruiz-Ruiz C., Robledo G., Cano E., Redondo J.M., Lopez-Rivas A. Characterization of p53-mediated up-regulation of CD95 gene expression upon genotoxic treatment in human breast tumor cells. Journal of Biological Chemistry 2003, 278:31667-31675.
37. Sallusto F., Geginat J., Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annual Review of Immunology 2004, 22:745-763.
38. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
39. Scheuring U.J., Sabzevari H., Theofilopoulos A.N. Proliferative arrest and cell cycle regulation in CD8(+)CD28(-) versus CD8(+)CD28(+) T cells. Human Immunology 2002, 63:1000-1009.
40. Schwendemann J., Choi C., Schirrmacher V., Beckhove P. Dynamic differentiation of activated human peripheral blood CD8+ and CD4+ effector memory T cells. The Journal of Immunology 2005, 175:1433-1439.
41. Simpson R.J., Cosgrove C., Ingram L.A., Florida-James G.D., Whyte G.P., Pircher H., et al. Senescent T-lymphocytes are mobilised into the peripheral blood compartment in young and older humans after exhaustive exercise. Brain, Behavior, & Immunity 2008, 22:544-551.
42. Simpson R.J., Florida-James G.D., Cosgrove C., Whyte G.P., Macrae S., Pircher H., et al. High-intensity exercise elicits the mobilization of senescent T lymphocytes into the peripheral blood compartment in human subjects. Journal of Applied Physiology 2007, 103:396-401.
43. Vallejo A.N., Schirmer M., Weyand C.M., Goronzy J.J. Clonality and longevity of CD4+CD28null T cells are associated with defects in apoptotic pathways. The Journal of Immunology 2000, 165:6301-6307.
44. Wang X., Pan L., Feng Y., Wang Y., Han Q., Han L., et al. P300 plays a role in p16(INK4a) expression and cell cycle arrest. Oncogene 2008, 27:1894-1904.
45. Wikby A., Johansson B., Olsson J., Lofgren S., Nilsson B.O., Ferguson F. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Experimental Gerontology 2002, 37:445-453.
46. Ye J., Huang X., Hsueh E.C., Zhang Q., Ma C., Zhang Y., et al. Human regulatory T cells induce T-lymphocyte senescence. Blood 2012, 120:2021-2031.
47. Zanni F., Vescovini R., Biasini C., Fagnoni F., Zanlari L., Telera A., et al. Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Experimental Gerontology 2003, 38:981-987.